Tucson, Arizona Clinical Trials

A listing of Tucson, Arizona clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 39 clinical trials
Safety and Efficacy of Lenvatinib (E7080/MK-7902) With Pembrolizumab (MK-3475) in Combination With Transarterial Chemoembolization (TACE) in Participants With Incurable/Non-metastatic Hepatocellular Carcinoma (MK-7902-012/E7080-G000-318/LEAP-012)

The purpose of this study is to evaluate the efficacy and safety of lenvatinib and pembrolizumab in combination with TACE versus TACE plus oral and intravenous (IV) placebos in participants with incurable, non-metastatic hepatocellular carcinoma (HCC). The primary hypotheses are that pembrolizumab plus lenvatinib in combination with TACE is superior …

carcinoma
hcv infection
hepatitis
antihypertensive agents
pembrolizumab
Arizona Oncology Associates PC- HOPE ( Site 0770)
 (2.5 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +37 other locations
JSI-1187-01 Monotherapy and in Combination With Dabrafenib for Advanced Solid Tumors With MAPK Pathway Mutations

This is a Phase 1 study of JSI-1187 as monotherapy and in combination with dabrafenib for the treatment of advanced solid tumors with MAPK pathway mutations, including mutations that cause MAPK pathway hyperactivation.

non-small cell lung cancer
experimental therapy
investigational treatment
adjuvant
ipilimumab
University of Arizona Comprehensive Cancer Center
 (1.7 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +3 other locations
A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine

The reason for this study is to see if lasmiditan is safe and effective in children aged 6 to 17 with migraine. The study will last up to 20 weeks and may include up to 4 visits.

migraine
lasmiditan
preventive medication
treatment regimen
ly573144
Center for Neurosciences
 (6.0 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +162 other locations
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)

The reason for this study is to see how safe and effective the study drug donanemab is in participants with early Alzheimer's disease.

flortaucipir
alzheimer's disease
positron emission tomography
mini-mental state examination
florbetapir
Banner Alzheimer's Institute
 (6.0 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +85 other locations
Follow-up Study of Growth Safety and Efficacy of an Infant Formula for Healthy Term Infants

The purpose of this two-month follow-up study is to continue to follow growth, safety, and other health outcomes of infants fed a new infant formula for term infants or comparator formula. A reference group of human milk-fed infants will also be followed. This study is designed in accordance with Good …

Watching Over Mothers and Babies
 (3.3 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +24 other locations
A Safety Study of Oral Venetoclax in Combination With Intravenous Pembrolizumab in Adult Participants With Previously Untreated Non-Small Cell Lung Cancer (NSCLC) With High Programmed Cell Death Ligand-1 (PD-L1) Expression

Non-Small Cell Lung Cancer (NSCLC) is a solid tumor, a disease in which cancer cells form in the tissues of the lung. It is the most common form of lung cancer, accounting for around 85% of lung cancers. The purpose of this study is to evaluate the safety and efficacy …

small cell lung cancer
lymphoma
stage iv non-small cell lung cancer
measurable disease
drug test
Arizona Oncology Associates, PC-HOPE (Rudasill) /ID# 216984
 (8.8 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +38 other locations
Tipifarnib for the Treatment of Advanced Solid Tumors Lymphoma or Histiocytic Disorders With HRAS Gene Alterations a Pediatric MATCH Treatment Trial

This phase II pediatric MATCH trial studies how well tipifarnib works in treating patients with solid tumors that have spread to other places in the body (advanced), lymphoma, or histiocytic disorders that have HRAS genetic alterations. Tipifarnib may block the growth of cancer cells that have specific genetic changes in …

lymphoma
blood count
platelet transfusion
MRI
bone marrow infiltration
Banner University Medical Center - Tucson
 (1.9 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +82 other locations
Investigation of Antibody and Immune Responses to SARS-CoV-2 Proteins

SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), has negatively impacted global health and requires more research to develop better tests and to improve disease treatment. The purpose of this research is to aid in the testing effort by collecting samples from people who have been diagnosed with COVID-19 …

covid-19
SARS
acute respiratory syndrome (sars)
coronavirus infection
TMC HealthCare
 (3.3 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
Feasibility of Passive Data Collection in Dementia Subjects With Agitation

This is a multi-center, observational, feasibility study, to evaluate long term passive data collection, data quality, and user experience of HealthMode Agitation (Apps) to collect motion, location, physiological, and audio data; and eCOA and EMA responses with mobile devices (iPhone, Apple Watch). The purpose of this study is to evaluate …

functional activities
agitation
dementia
Tucson Neuroscience Research, LLC
 (6.2 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location